Main Conclusions Key Findings I. Overview of the Global Biopharmaceuticals Market in 2006 (I) Market Size and Characteristics 1. Market Size and Growth in 2006 2. Market Characteristics in 2006 3. Application of Advanced Technology (II) Major Countries & Regions 1. U.S.A. 2. Europe 3. Denmark 4. Singapore II. Overview of China's Biopharmaceutical Industry, 2005-2006 (I) Development Environment 1. Policy Environment 2. Investment Environment 3. Market Environment 4. Information Service Environment (II) Present Situation 1. Industry Size 2. Molecular Biology 3. Pharmaceutical 4. Biological Equipment & Methods 5. Biological Evolution & Ecology 6. Plant Biopharmaceuticals 7. Animal Biopharmaceuticals (III) Characteristics 1. New technology becomes main conventional method for the research and development of biopharmaceuticals 2. Cross-regional division of work become finer in the industry 3. The high-end R&D of new products dramatically boosts the industry's competitiveness 4. Outsourcing becomes biopharmaceutical enterprises' important development strategy (IV) Existing Problems 1. Low Industrialization Degree, Long Productization Cycle 2. Poor Innovation, Lack of Key Technologies 3. Loose Market Regulation, Reduced Product Credibility (V) Industry Segments 1. Genetic Engineering Drugs 2. Antibody Engineering Pharmaceutics 3. Blood Products 4. Vaccine 5. Diagnosis Reagents 6. Biochips 7. Chemical Medicine 8. Traditional Chinese Medicine III. Analysis of the Layout of China's Biopharmaceutical Industry (I) Present Regional Industry Layout 1. Overall Layout 2. Northeast 3. North China 4. East China 5. Southwest 6. Northwest (II) Characteristics of Regional Industry Layout 1. Enterprises in the northeast and southwest focus on productization, and those in the central regions are dedicated to research and development 2. Foreign-oriented enterprises and foreign-invested enterprises are densely distributed in the coastal areas; enterprises in the hinterland are largely oriented toward the domestic market (III) Development Trend of Regional Industry Layout 1. Cross-regional division of work become finer in the industry 2. HR-oriented regions and application-oriented regions strength cooperation 3. There is a notable trend of competition and cooperation between enterprises across regions IV. Analysis of the Attractiveness of Chinese Development Zones to the Biopharmaceutical Industry in 2006 (I) Key Elements of the Attractiveness of the Development Zones 1. Industry Clusters 2. Generic Technology Platform 3. Policy Environment 4. Basic Services 5. Investment & Financing Environment (II) Major Development Zones' Strategies 1. Beijing Zhongguancun Bio-Medicine Garden 2. Tianjin Economic-technological Development Area 3.... V. Development Trend of the Biopharmaceutical Industry in Chinese Development Zones, 2007-2009 (I) Policy Factors (II) Economic Factors (III) Service Factors (IV) Technology Platform (V) Investment & Financing VI. Assessment of the Attractiveness of the Biopharmaceutical Industry in Chinese Development Zones, 2007-2009 (I) Index System (II) Assessment of Attractiveness 1. Overall Ranking 2. Ranking by Elements VII. Recommendations from Our. (I) Strategic Recommendations (II) Investment Recommendations List of Tables Market Size of China's Biopharmaceutical Industry, 2005-2006 Market Size of the Biopharmaceutical Industry in Chinese Development Zones in 2006 Market Size of the Biopharmaceuticals R&D Industry in Chinese Development Zones in 2006 Market Size of the Biopharmaceuticals Manufacturing Industry in Chinese Development Zones in 2006 Layout of the Biopharmaceutical Industry in Chinese Development Zones in 2006 ... List of Figures Market Size of the Global Biopharmaceutical Industry, 2006-2007 Development of China's Biopharmaceutical Industry, 2006-2007 Development of the Biopharmaceutical Industry in the Development Zones, 2006-2007 Size of the Segments of the Biopharmaceutical Industry in the Development Zones, 2006-2007 Development Trend of the Attractiveness of the Segments of the Biopharmaceutical Industry in the Development Zones, 2006-2007 ... Report's synopsisIn 2006, sales of biopharmaceuticals enterprises in Chinese development zones grew steadily by some 20%; yet profit evidently slowed down. Competition between development zones in the field of biopharmaceuticals shifts from policy environment to services. The establishment of technology platforms becomes an important means. Overview of development zones: Development zones offering generic technology platforms are more attractive to biopharmaceuticals enterprises. Moreover, development zones providing investment/financing and HR services also hold considerable competitiveness. Development zones offering these services become biopharmaceutical enterprises' preferred choice In the face of competition and changes and challenges in the market, Our releases the 2006-2007 Annual Report on the Attractiveness of Chinese Development Zones to the Biopharmaceutical Industry. It will help vendors, investors, and industry chain grasp more accurately the model under which Chinese development zones develop the biopharmaceutical industry, and comb development zones' application value more deeply: Backed by full and accurate market description data, the report depicts the development of the development zones in 2006 from the dimensions of policy environment, basic services, platforms, investment environment, and development environment in the local areas, to discern development trends. After examining the competition performance of major development zones in 2006, it sums up their successes and failures from the dimension of service quality, meeting of requirements, and investment environment, and reviews the makings of leading players. It presents in-depth quantitative forecast of the market, assesses the measures taken by development zones to develop biopharmaceuticals, and ranks the development zones. Moreover, it examines impetuses and obstacles to development zones' attractiveness to the biopharmaceutical industry, and conducts multidimensional analysis of user demand. 
|